Novartis AG
https://www.novartis.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Novartis AG
ChatGPT Unleashed: Generative AI Use Cases Taking Off In Pharma
As generative AI and its star avatar, ChatGPT, take the world by storm, pharma is seeing traction for use cases around smarter pharmacovigilance and commercial marketing content development, among others. Senior executives from Indegene discuss this and more in an interview with Scrip.
Falling At The Start Line: Chinese Firms Face Multiple Commercial Challenges Beyond Price, Coverage
Sales of a global first-in-class dermatology drug that gained its first approval in China are falling well behind those of its overseas counterpart. Brian Yang takes a deeper look into the multiple underlying factors determining success in the world's second-largest pharma market beyond pricing and reimbursement coverage, including complex hospital entry, dual channels and competition considerations.
ASCO 2023 – Novartis’s Adjuvant Breast Cancer Win Comes With Caveats
The Natalee trial hits in all-comers, but an equivocal showing in node-negative patients raises questions about market expansion.
Allogene May Have Cracked The Off-The-Shelf CAR-T Problem
Allogeneic candidate’s durability is holding up thanks to a novel conditioning regimen, but Phase II data will be crucial test.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Admune Therapeutics
- Amblyotech, Inc.
- Advanced Accelerator Applications SA (AAAP) (BioSynthema, Inc.)
- Aspen Japan K.K.
- Biocine
- CELLforCURE SASU
- Chiron Corporation
- CIBA-GEIGY
- Corthera Inc.
- CoStim Pharmaceuticals Inc.
- ESBATech AG
- Fougera Pharmaceuticals, Inc.
- Gyroscope Therapeutics Limited
- Hexal AG
- Lek Pharmaceuticals, Inc.
- Matrix Pharmaceuticals
- NeuTec Pharma
- Novartis Groupe France S.A.
- Novartis Pharmaceuticals
- Novartis Oncology
- Novogyne Pharmaceuticals (joint venture between Noven and Novartis)
- PowerVision, Inc.
- Protez Pharmaceuticals
- Sandoz Pharmaceuticals (Ever Neuro Pharma GmbH
- Ebewe Pharma)
- Selexys Pharmaceuticals Corporation
- Speedel Holding
- Spinifex Pharmaceuticals Pty. Ltd.
- Transcend Medical, Inc.
- Encore Vision, Inc.
- Ziarco Group Limited
- AveXis, Inc.
- BioLife Cell Bank, Inc.
- Endocyte, Inc.
- IFM Tre
- Zyma SA
- Annovation Biopharma, Inc.
- Boxford Subsidiary
- Curacyte Discovery GmbH
- Incline Therapeutics, Inc.
- ProFibrix B.V.
- Rempex Pharmaceuticals, Inc.
- Targanta Therapeutics Corporation
- Tenaxis Medical
- The Medicines Company
- Novartis Gene Therapies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice